Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORMETAZEPAM Cause Disturbance in attention? 33 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Disturbance in attention have been filed in association with LORMETAZEPAM. This represents 1.1% of all adverse event reports for LORMETAZEPAM.

33
Reports of Disturbance in attention with LORMETAZEPAM
1.1%
of all LORMETAZEPAM reports
0
Deaths
18
Hospitalizations

How Dangerous Is Disturbance in attention From LORMETAZEPAM?

Of the 33 reports, 18 (54.5%) required hospitalization, and 13 (39.4%) were considered life-threatening.

Is Disturbance in attention Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORMETAZEPAM. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does LORMETAZEPAM Cause?

Drug abuse (488) Coma (426) Toxicity to various agents (315) Somnolence (310) Fall (246) Poisoning deliberate (218) Intentional overdose (187) Drug dependence (181) Overdose (157) Suicide attempt (150)

What Other Drugs Cause Disturbance in attention?

LEVOTHYROXINE (1,718) METHYLPHENIDATE (1,414) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (1,321) DULOXETINE (986) PREGABALIN (950) LISDEXAMFETAMINE DIMESYLATE (911) OXYCODONE (829) QUETIAPINE (747) ACETAMINOPHEN\HYDROCODONE (746) ACETAMINOPHEN\OXYCODONE (734)

Which LORMETAZEPAM Alternatives Have Lower Disturbance in attention Risk?

LORMETAZEPAM vs LORNOXICAM LORMETAZEPAM vs LOSARTAN LORMETAZEPAM vs LOSARTAN\LOSARTAN LORMETAZEPAM vs LOTEPREDNOL ETABONATE LORMETAZEPAM vs LOTEPREDNOL ETABONATE\TOBRAMYCIN

Related Pages

LORMETAZEPAM Full Profile All Disturbance in attention Reports All Drugs Causing Disturbance in attention LORMETAZEPAM Demographics